| Dr Michael D Winniford, MD | |
|
2500 North State Street, Department Of Medicine/division Of Cardiology, Jackson, MS 39216-4500 | |
| (601) 984-5630 | |
| Not Available |
| Full Name | Dr Michael D Winniford |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Interventional Cardiology |
| Location | 2500 North State Street, Jackson, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083647879 | NPI | - | NPPES |
| 1461351 | Medicaid | LA | |
| 0125909 | Medicaid | MS | |
| RR 060068580 | Other | MS | RAILROAD |
| 126125 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 17665 (Mississippi) | Secondary |
| 207RI0011X | Internal Medicine - Interventional Cardiology | 17665 (Mississippi) | Primary |
| Entity Name | Rush Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588625594 PECOS PAC ID: 2567368541 Enrollment ID: O20031210000541 |
News Archive
Codexis, Inc. announced today the pricing of its initial public offering of 6,000,000 shares of its common stock, at $13.00 per share. All shares are being sold by the company. Codexis has granted the underwriters an option to purchase up to an additional 900,000 shares at the initial public offering price to cover overallotments, if any. The common stock will trade on the NASDAQ Global Market under the symbol "CDXS."
Hispanic voters are troubled by the direction of the country and are very concerned about the economy, spending, debt and national security, according to a new Resurgent Republic survey. The study, released today, showed that most are responsive to fiscally conservative messages and believe that President Obama is pursuing a different main priority on health care than what they think should be the top priority.
The earlier that autism is diagnosed and treated in children, the better outcomes they will experience for future relationships and careers.
Roche has announced results from a study demonstrating that the new boosted dosing regimen for its protease inhibitor Invirase(R) (saquinavir 1000 mg with ritonavir 100 mg twice-daily) has no significant interactions when it is co-administered with tenofovir disoproxil fumarate (300 mg once-daily).
› Verified 9 days ago
| Entity Name | Laird Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821046798 PECOS PAC ID: 7214991769 Enrollment ID: O20050201000304 |
News Archive
Codexis, Inc. announced today the pricing of its initial public offering of 6,000,000 shares of its common stock, at $13.00 per share. All shares are being sold by the company. Codexis has granted the underwriters an option to purchase up to an additional 900,000 shares at the initial public offering price to cover overallotments, if any. The common stock will trade on the NASDAQ Global Market under the symbol "CDXS."
Hispanic voters are troubled by the direction of the country and are very concerned about the economy, spending, debt and national security, according to a new Resurgent Republic survey. The study, released today, showed that most are responsive to fiscally conservative messages and believe that President Obama is pursuing a different main priority on health care than what they think should be the top priority.
The earlier that autism is diagnosed and treated in children, the better outcomes they will experience for future relationships and careers.
Roche has announced results from a study demonstrating that the new boosted dosing regimen for its protease inhibitor Invirase(R) (saquinavir 1000 mg with ritonavir 100 mg twice-daily) has no significant interactions when it is co-administered with tenofovir disoproxil fumarate (300 mg once-daily).
› Verified 9 days ago
| Entity Name | Yalobusha General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740380914 PECOS PAC ID: 4486601648 Enrollment ID: O20050331000530 |
News Archive
Codexis, Inc. announced today the pricing of its initial public offering of 6,000,000 shares of its common stock, at $13.00 per share. All shares are being sold by the company. Codexis has granted the underwriters an option to purchase up to an additional 900,000 shares at the initial public offering price to cover overallotments, if any. The common stock will trade on the NASDAQ Global Market under the symbol "CDXS."
Hispanic voters are troubled by the direction of the country and are very concerned about the economy, spending, debt and national security, according to a new Resurgent Republic survey. The study, released today, showed that most are responsive to fiscally conservative messages and believe that President Obama is pursuing a different main priority on health care than what they think should be the top priority.
The earlier that autism is diagnosed and treated in children, the better outcomes they will experience for future relationships and careers.
Roche has announced results from a study demonstrating that the new boosted dosing regimen for its protease inhibitor Invirase(R) (saquinavir 1000 mg with ritonavir 100 mg twice-daily) has no significant interactions when it is co-administered with tenofovir disoproxil fumarate (300 mg once-daily).
› Verified 9 days ago
| Entity Name | Scott Regional Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639367188 PECOS PAC ID: 0648366260 Enrollment ID: O20080423000448 |
News Archive
Codexis, Inc. announced today the pricing of its initial public offering of 6,000,000 shares of its common stock, at $13.00 per share. All shares are being sold by the company. Codexis has granted the underwriters an option to purchase up to an additional 900,000 shares at the initial public offering price to cover overallotments, if any. The common stock will trade on the NASDAQ Global Market under the symbol "CDXS."
Hispanic voters are troubled by the direction of the country and are very concerned about the economy, spending, debt and national security, according to a new Resurgent Republic survey. The study, released today, showed that most are responsive to fiscally conservative messages and believe that President Obama is pursuing a different main priority on health care than what they think should be the top priority.
The earlier that autism is diagnosed and treated in children, the better outcomes they will experience for future relationships and careers.
Roche has announced results from a study demonstrating that the new boosted dosing regimen for its protease inhibitor Invirase(R) (saquinavir 1000 mg with ritonavir 100 mg twice-daily) has no significant interactions when it is co-administered with tenofovir disoproxil fumarate (300 mg once-daily).
› Verified 9 days ago
| Entity Name | State Of Mississippi - University Of Mississippi Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154317527 PECOS PAC ID: 1850293036 Enrollment ID: O20090414000575 |
News Archive
Codexis, Inc. announced today the pricing of its initial public offering of 6,000,000 shares of its common stock, at $13.00 per share. All shares are being sold by the company. Codexis has granted the underwriters an option to purchase up to an additional 900,000 shares at the initial public offering price to cover overallotments, if any. The common stock will trade on the NASDAQ Global Market under the symbol "CDXS."
Hispanic voters are troubled by the direction of the country and are very concerned about the economy, spending, debt and national security, according to a new Resurgent Republic survey. The study, released today, showed that most are responsive to fiscally conservative messages and believe that President Obama is pursuing a different main priority on health care than what they think should be the top priority.
The earlier that autism is diagnosed and treated in children, the better outcomes they will experience for future relationships and careers.
Roche has announced results from a study demonstrating that the new boosted dosing regimen for its protease inhibitor Invirase(R) (saquinavir 1000 mg with ritonavir 100 mg twice-daily) has no significant interactions when it is co-administered with tenofovir disoproxil fumarate (300 mg once-daily).
› Verified 9 days ago
| Entity Name | Kemper Cah, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346546306 PECOS PAC ID: 5991985012 Enrollment ID: O20110622000294 |
News Archive
Codexis, Inc. announced today the pricing of its initial public offering of 6,000,000 shares of its common stock, at $13.00 per share. All shares are being sold by the company. Codexis has granted the underwriters an option to purchase up to an additional 900,000 shares at the initial public offering price to cover overallotments, if any. The common stock will trade on the NASDAQ Global Market under the symbol "CDXS."
Hispanic voters are troubled by the direction of the country and are very concerned about the economy, spending, debt and national security, according to a new Resurgent Republic survey. The study, released today, showed that most are responsive to fiscally conservative messages and believe that President Obama is pursuing a different main priority on health care than what they think should be the top priority.
The earlier that autism is diagnosed and treated in children, the better outcomes they will experience for future relationships and careers.
Roche has announced results from a study demonstrating that the new boosted dosing regimen for its protease inhibitor Invirase(R) (saquinavir 1000 mg with ritonavir 100 mg twice-daily) has no significant interactions when it is co-administered with tenofovir disoproxil fumarate (300 mg once-daily).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael D Winniford, MD 2500 North State Street, Jackson, MS 39216-4500 Ph: (601) 984-5678 | Dr Michael D Winniford, MD 2500 North State Street, Department Of Medicine/division Of Cardiology, Jackson, MS 39216-4500 Ph: (601) 984-5630 |
News Archive
Codexis, Inc. announced today the pricing of its initial public offering of 6,000,000 shares of its common stock, at $13.00 per share. All shares are being sold by the company. Codexis has granted the underwriters an option to purchase up to an additional 900,000 shares at the initial public offering price to cover overallotments, if any. The common stock will trade on the NASDAQ Global Market under the symbol "CDXS."
Hispanic voters are troubled by the direction of the country and are very concerned about the economy, spending, debt and national security, according to a new Resurgent Republic survey. The study, released today, showed that most are responsive to fiscally conservative messages and believe that President Obama is pursuing a different main priority on health care than what they think should be the top priority.
The earlier that autism is diagnosed and treated in children, the better outcomes they will experience for future relationships and careers.
Roche has announced results from a study demonstrating that the new boosted dosing regimen for its protease inhibitor Invirase(R) (saquinavir 1000 mg with ritonavir 100 mg twice-daily) has no significant interactions when it is co-administered with tenofovir disoproxil fumarate (300 mg once-daily).
› Verified 9 days ago
Graves Crawley Stubblefield Jr., M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 406 Briarwood Dr, Jackson, MS 39206 Phone: 601-991-1933 Fax: 601-978-3844 | |
Dr. Rebecca Chick Pace, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 N State St, Suite 500, Jackson, MS 39202 Phone: 601-352-2273 Fax: 601-714-3415 | |
Jewelian Akbar Baig, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 971 Lakeland Dr Ste 356, Jackson, MS 39216 Phone: 601-200-4644 Fax: 601-200-4645 | |
Jo P Deal, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 766 Lakeland Dr # A, Jackson, MS 39216 Phone: 601-368-3440 Fax: 601-368-3441 | |
Caryl P. Sumrall, FNP Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2500 North State Street, Department Of Medicine/division Of General Internal Med, Jackson, MS 39216 Phone: 601-984-5660 | |
Meghan Alford Luter, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5532 | |
Tammy H Young, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1227 N State St, Ste 101, Jackson, MS 39202 Phone: 601-355-2485 Fax: 601-353-1463 |